Sessile serrated lesions in patients with adenoma on index colonoscopy do not increase metachronous advanced adenoma risk
- PMID: 34608684
- DOI: 10.1111/den.14159
Sessile serrated lesions in patients with adenoma on index colonoscopy do not increase metachronous advanced adenoma risk
Abstract
Objectives: Post-polypectomy surveillance intervals should be determined based on index colonoscopy findings. However, the risk of metachronous lesions, resulting from the coexistence of adenoma and sessile serrated lesions (SSLs), has rarely been addressed. We evaluated the impact of synchronous SSL on the risk of metachronous lesions within similar adenoma risk groups.
Methods: We retrieved individuals with one or more adenomas on index colonoscopy in a single-center retrospective cohort and stratified them into four groups depending on the presence of SSL and low-risk/high-risk adenoma (LRA/HRA). Participants who underwent surveillance colonoscopies at least 12 months apart were included. We compared the risks of metachronous lesions including HRA, advanced adenoma (AA), or SSL within similar adenoma risk groups according to the presence of SSL.
Results: Overall 4493 individuals were included in the analysis. The risk of metachronous HRA/AA was not significantly higher in the adenoma with SSL group compared with the adenoma without SSL group, irrespective of LRA (HRA, 6/86 vs. 231/3297, P = 1.00; AA, 0/86 vs. 52/3297, P = 0.64) or HRA (HRA, 11/64 vs. 240/1046, P = 0.36; AA, 3/64 vs. 51/1046, P = 1.00). However, the risk of metachronous SSL in individuals with synchronous SSL was higher than that in those without SSL for both LRA (15/86 vs. 161/3297, P < 0.001) and HRA groups (11/64 vs. 61/1046, P = 0.002).
Conclusion: The presence of synchronous SSL did not increase the risk of metachronous HRA/AA, compared with isolated adenoma, but increased the risk of metachronous SSL.
Keywords: adenoma; cohort study; colonic polyp; colonoscopy; risk assessment.
© 2021 Japan Gastroenterological Endoscopy Society.
Comment in
-
Synergistic or independent? Revisiting colonoscopic surveillance for conventional and serrated lesions.Dig Endosc. 2022 May;34(4):858-861. doi: 10.1111/den.14227. Epub 2022 Jan 20. Dig Endosc. 2022. PMID: 35048427 No abstract available.
References
-
- Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-100.
-
- Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: Review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315-29.
-
- Crockett SD, Nagtegaal ID. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology 2019; 157: 949-66.e4.
-
- Wong MC, Ding H, Wang J, Chan PS, Huang J. Prevalence and risk factors of colorectal cancer in Asia. Intest Res 2019; 17: 317-29.
-
- Rosty C, Brosens L, Dekker E, Nagtegaal I. Serrated polyposis. In: WHO Classification of Tumours Editorial Board (ed). Digestive System Tumours, WHO Classification of Tumours, 5th edn. IARC Press, Lyon, 2019; 532-4.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical